Top 50 Biotechnology Angel Investors in July 2025

Investor	Biotechnology investments
Jonathan Milner	34
Milad Alucozai	22
Jeff Dean	15
Jude Gomila	12
Paul Buchheit	10
Jaffray Woodriff	10
Jeff Hammerbacher	9
bumpkins profile	9
Kingsley Advani	9
Alice Zhang	8
Jim Mellon	8
Balaji Srinivasan	8
Sam Altman	7
Chris Gibson	7
Sahin Boydas	7
Wei Guo	7
Nadav Rosenberg	6
Bradley Horowitz	6
Zach Weinberg	6
Elad Gil	6
Stefano Bernardi	6
Evan Cheng	6
Peter Thiel	5
Daniel Curran	5
Jan Hammer	5
Kevin Moore	5
Anne Wojcicki	5
Charlie Songhurst	5
Sake Bosch	5
Bhavik Bajaj	5
Cory Levy	5
Farzad (Zod) Nazem	5
Brian Armstrong	5
Erik Peterson	5
Mark Cuban	5
Xavier Niel	4
Martin Chavez	4
Tom Williams	4
Bernard Majoie	4
Rand Hindi	4
Daren Cotter	4
T. Chen Fong	4
Bill Gates	4
Jack Abraham	4
Candan Karabagli	4
Penny Schiffer	4
Avichal Garg	4
Annie Vereecken	4
David Beyer	4
John D'Orazio	4

Having worked in the life sciences industry for over ten years as an academic researcher, Jonathan identified the market opportunity for supplying high quality antibodies to support protein interaction studies and, in 1998, founded Abcam with David Cleevely and Professor Tony Kouzarides. Jonathan is a Non-Executive Director of Horizon DiscoveryGroup plc, The Evolution Education Trust, GeoSpock Ltd and Sydicate Room Group Ltd. He is also Chairman of Axol Bioscience Ltd, PhoreMost Ltd, Repositive Limited, Definigen Limited and Cambridge Allergy Ltd. Jonathan holds an executive director position at Meltwind Limited, being a designated member of Meltwind Advisory LLP. Jonathan is an experienced entrepreneur and investor and is passionate about supporting UK life science and high-tech start-ups. He has provided considerable investment and support to over 30 companies and has assisted three AIM IPOs.

Investment focus

Biotechnology, Health Care, Medical
Seed, Series A, Series B
United Kingdom, United States, Spain

Portfolio highlights

Quibim — Leading radiomics company pioneering quantitative imaging biomarkers and medical applications in precision medicine.
52 North Health — At 52 North we are developing fully-integrated clinical, AI and medical-device based systems.
Exciting Instruments — We're on a mission to simplify single-molecule fluorescence spectroscopy and make it accessible to all. Find out more about our company, our products and what makes us different now.

Dr. Milad Alucozai specializes in translating scientific and technological breakthroughs into scalable commercial ventures. As an Afghan-American neuroscientist, entrepreneur, and global investor, he leverages his expertise in bioengineering, computational biology, and machine learning to identify promising innovations and develop strategies fortheir successful market entry and growth. He focuses on accelerating the process of bringing groundbreaking discoveries from the lab to market, particularly in the life sciences and computationally-driven fields.Dr. Alucozai is a co-founder of Revalia Bio, which aims to create a human-centric infrastructure for drug discovery and development. By utilizing non-transplantable human organs donated for research, Revalia provides the scientific community unparalleled insights into patient biology, ultimately aiding in the development of better treatments and cures. In 2024, he partnered with The Wyss Institute at Harvard University to launch and co-host the popular "Code to Cure" series, exploring the convergence of AI, biology, and healthcare. He also contributes his expertise as a Senior Fellow in Healthcare Engineering at the Regenstrief Center.His background includes leading 70 early-stage investments as Head of Bio and Deep Tech at BoxOne Ventures, establishing the firm as a key player in North America's VC landscape. He also served as a Venture Partner at Entrepreneur First, a globally recognized talent investor backed by notable figures like Patrick and John Collison of Stripe and Reid Hoffman of LinkedIn, with a portfolio exceeding $10 billion in value. He mentors entrepreneurs across North America and Europe through channels like the Creative Destruction Lab.Throughout his operating and investing career, he has been instrumental in helping founders secure hundreds of millions in capital and facilitating over $1 billion in startup-pharma partnerships. Often serving as the first investor, he guides companies from concept to successful exit and shapes business development for high-growth, venture-backed startups. His advisory work also extends to established corporations; at Accenture, he led teams advising top pharmaceutical companies on their R&D, innovation, and business development strategies. In 2020, he formally served as an External Advisor to AstraZeneca.He was a National Science Foundation Scholar and Macklin Fellow at Johns Hopkins Medicine. He graduated Phi Beta Kappa with a Neuroscience degree from Purdue University’s Honors Program, earned a master’s in Immunology and Public Health as a George J. Mitchell Scholar, and holds a doctorate from the Richard M. Fairbanks School of Public Health. Additionally, he completed a visiting scholarship at the Wyss Institute at Harvard University.

Investment focus

Biotechnology, Health Care, Medical
Seed, Series A, Pre-Seed
United States, Canada, United Kingdom

Portfolio highlights

Arpeggio Bio — We engineer medicine based not on a single target, but the biological network as a whole.
Future Fields — Future Fields Cellular Agriculture: Serum-Free Growth Media Supplements and Recombinant Proteins - Optimized for the Future of Food.
Eigen Therapeutics — Eigen Therapeutics is a biotechnology company developing combination therapeutics for cancer. The company is in the research and development of synergistic therapies that improve efficacy while reducing the toxicity of small molecule therapies and immunotherapies, enabling physicians to get access to novel drugs in areas of unmet medical needs.

Jeff Dean is the Chief Scientist of Google DeepMind and Google Research. He joined Google in 1999 and has played a pivotal role in shaping the company’s technical foundations. He currently focuses on advancing AI and deep learning research across Google’s research teams.He co-founded and led the Google Brain team, helping drive innovations indeep learning for speech recognition, computer vision, natural language understanding, and a wide range of predictive applications. Over the years, he has co-designed and implemented several generations of Google's core systems, including its web search infrastructure, crawling and indexing pipelines, and advertising technologies such as AdSense for Content.He is also a key contributor to Google's distributed computing infrastructure, having co-designed and implemented systems like MapReduce, BigTable, Spanner, Protocol Buffers, LevelDB, and TensorFlow—one of the most widely used open-source machine learning platforms.Jeff Dean earned his Ph.D. in Computer Science from the University of Washington in 1996. He is a Fellow of the ACM, a member of the U.S. National Academy of Engineering and the American Academy of Arts and Sciences, and a recipient of the ACM-Infosys Foundation Award in the Computing Sciences and the Mark Weiser Award.

Investment focus

Artificial Intelligence, Information Technology, Software
Seed, Series A, Pre-Seed
United States, United Kingdom, Japan

Portfolio highlights

Akido Labs — At Akido, we collaborate with healthcare, government, and non-profit institutions to implement programs that tackle inequities in public health.
Emerald AI — Emerald AI creates a platform that enables AI data centers to adjust power consumption from electricity grids dynamically. This system orchestrates computing loads across data centers to bolster grid reliability. The technology aims to advance AI innovation while ensuring power affordability and electric system stability.
Parallel Bio — Using the immune system to cure disease. Parallel Bio uses a human immune system in a dish and AI to discover drugs more likely to work in patients.

Jude Gomila is currently CEO and Founder of the startup Golden.

Investment focus

Software, Biotechnology, Information Technology
Seed, Pre-Seed, Angel
United States, United Kingdom, Canada

Portfolio highlights

Parcha AI — Parcha is an AI-powered enterprise software that enables businesses to automate their scale compliance and operations.
HockeyStack — HockeyStack enables marketing teams to drive pipeline efficiently and sales teams to close deals faster with modern attribution, holistic buyer journeys, and account insights.
Farmako — Install Farmako app, get a free health ID and get all your medical records safe and secure in one place!

Paul Buchheit co-founded social network aggregator FriendFeed, along with three other former Google employees. He is also an investor in FriendFeed and participated in a $5 million Series A round in February 2008.He was the 23rd employee at Google, where he created Gmail and implemented many of its innovative features. He developed the originalprototype of Google AdSense, and was responsible for Google's famous "Don't be evil" motto in a meeting.

Investment focus

Software, Health Care, E-Commerce
Seed, Series A, Angel
United States, Canada, India

Portfolio highlights

SiPhox Health — SiPhox Health brings comprehensive, at-home blood testing to your door! Take control of your disease risk and increase your healthspan today with affordable, convenient at-home blood testing. No lab visits, no appointments, no waiting in line.
Character.ai — Chat with millions of AI Characters on the #1 AI chat app. Where will your next adventure take you?
Perplexity — Perplexity is a search engine platform that uses artificial intelligence to provide large language models and search engines. The company's platform enables the development of beneficial artificial general intelligence, as well as an open-source environment that is accessible to the public, allowing clients to develop skills and knowledge inartificial intelligence.

Angel Investor located in Charlottesville, VA

Investment focus

Software, Biotechnology, Health Care
Seed, Series A, Angel
United States

Portfolio highlights

Yogi — Yogi's analytics platform lets you easily sift through customer Reviews & Ratings data. Get actionable insights from your product Reviews, Ratings, and Sentiment Analysis to improve your brand reputation and product experiences.
Caju AI — Caju AI revolutionizes customer engagement with Generative AI, boosting your workforce's productivity and providing invaluable business insights. Elevate your customer experience with the power of AI.
Starchive — AI enriched Digital Asset Management designed by creators for creators, to maximize the control and ownership of their content, community, and commerce in the Visual Media Economy.

Jeff Hammerbacher - Partner & Co-Founder @ Techammer

Investment focus

Software, Artificial Intelligence, Biotechnology
Seed, Series A, Angel
United States

Portfolio highlights

257 — The residential energy data platform
Lamin — Lamin Labs provides data infrastructure for biology that enables data scientists and engineers to collaborate on a single data layer for R&D teams of any size. They want to achieve for R&D data what git and GitHub did for code by integrating wet and dry laboratories, people and AI, knowledge and data, and siloed teams and organizations.Lamin Labs is headquartered in Munich, Bayern and was founded in 2022.
Inductive Bio — Bringing the data, ML, software, and expertise needed to rapidly solve your most challenging ADMET problems.

blah - teh software was teh busted and they didn't want to fix it or hire someone to fix it, odd folks, these.

Investment focus

Health Care, Biotechnology, Software
Seed, Series A, Pre-Seed
United States, Canada, India

Portfolio highlights

Sorare — Global Fantasy Football. Collect limited edition digital collectibles, Manage your team and earn prizes!
Hoth Intelligence — Hoth Intelligence home page. Space age surgical technology brought down to earth.
Floating Point Group — Floating Point Group is a trading platform provider offering innovative, industry-leading trade execution and settlement

Kingsley Advani is a British investor. He started investing in 2013, funding 50 companies, 4 funds and donating to non-profits including: SENS Foundation, Methuselah Foundation, Stanford University, National University of Singapore. He is particularly interested in regenerative medicine for age-related disease. Investments: Oisin, Turn Bio,Oncosenx, Monzo, Robinhood, Abra, Coinbase, Momentus, Demonpores, 64-x, Nectome. Investment areas: biotechnology, neurotechnology, longevity, space, fintech.

Investment focus

FinTech, Financial Services, Biotechnology
Seed, Pre-Seed, Series A
United States, Singapore, United Kingdom

Portfolio highlights

Checkstep — AI Content Moderation Services: learn how AI can help you scale your content moderation and keep your users and moderators safe.
Allocations — 10,000+ investors and fund managers build, onboard and close funds on Allocations - the fastest and most advanced fund platform in the world
Ashvattha Therapeutics — Ashvattha Therapeutics creates products that selectively target and treat human diseases. Ashvattha enables precision targeting for therapeutics eliminating off-target toxicity, systemic side effects, and immunogenicity seen in other platforms. Ashvattha has a pipeline of nine therapeutics in neurology, oncology, and ophthalmology.

CEO and Co-founder at Verge Genomics; Angel Investor in Tech-Enabled Bio

Investment focus

Biotechnology, Health Care, Medical
Seed, Series A, Pre-Seed
United States, United Kingdom

Portfolio highlights

Encellin — Encellin develops a novel thin-film cell encapsulation device for cell-based therapeutics. It has dedicated experts focused on the investigation and advancement of next-generation therapies. It aims to help patients with chronic diseases, starting with Type 1 diabetes. It was founded in 2016 and is headquartered in San Francisco, California.
Ochre Bio — Ochre Bio is developing therapies for the biggest liver health challenges.
Arpeggio Bio — We engineer medicine based not on a single target, but the biological network as a whole.

Jim Mellon is an international investor with interests in several industries. After leaving Oxford, where he studied PPE, (Philosophy, Politics and Economics) he worked in Asia and the United States for two fund management companies, GT and Thornton, before establishing his own business in 1991. His business operations include two components, alisted fund management company called Charlemagne Capital, and an Asian mining group, Regent Pacific.In addition, Mr. Mellon is Co-Chairman of West African Minerals Corporation and Regent Pacific Group. He is on the board of a number of public quoted companies, including Brazilian Gold Corporation, Charlemagne Capital Limited, Manx Financial Group, Plethora Solutions, Polo Resources, Port Erin Biophara Investments Limited, and the Speymill plc. He is the life tenant of a trust which owns the Burnbrae Group, which has substantial assets in the biotechnology, financial services, property, mining and leisure sectors. Mr. Mellon spends most of his time working on startup ideas and investing. His book, “Wake Up!” was published in 2005; his second book "10 Investments for the Ten Years Ahead" was published in 2008. In 2012, he co-wrote "Cracking the Code" which focuses on the biotechnology sector and how to profit from it. Mr. Mellon lives in the Isle of Man, Brussels and Ibiza and is an honorary fellow of Oriel College, Oxford.

Investment focus

Biotechnology, Food and Beverage, Health Care
Series A, Seed, Funding Round
United States, United Kingdom, Germany

Portfolio highlights

Voxia — Amy collects and analyzes information from all over the web and provides actionable insights about your leads, prospects and clients, all in one click.
Monaco Foundry — We are a team of Serial Entrepreneurs, former Senior Government Advisors and Fortune 500 Executives. A global venture accelerator that invests in early to mid-stage companies and their growth through a unique sweat equity model.
The Duppy Share — The Duppy Share Caribbean Rum is the best rum for cocktails, mixed drinks and rum gifts. Try all our rum recipes, from rum and ginger to dark rum punch.

Balaji S. Srinivasan is the Co-Founder and Board Member of Coin Center. He was the CTO of Coinbase and cofounder of Counsyl, Earn, Teleport, and Coin Center. He was previously CEO at Earn.com, which was recently sold to Coinbase. Prior to taking the CEO role at Earn.com, Dr. Srinivasan was a General Partner at Andreessen Horowitz. Prior to joininga16z, he was the co-founder and CTO of Founders Fund-backed Counsyl, where he won the Wall Street Journal Innovation Award for Medicine and was named to the MIT TR35. Dr. Srinivasan holds a BS, MS, and PhD in Electrical Engineering and an MS in Chemical Engineering from Stanford University. He also teaches the occasional class at Stanford, including an online MOOC in 2013 which reached 250,000+ students worldwide.

Investment focus

Blockchain, Cryptocurrency, Software
Seed, Pre-Seed, Series A
United States, India, Singapore

Portfolio highlights

Aspora — Aspora help users bank seamlessly across countries, invest in diverse assets, access credit and insurance services.
Kindly MD — Kindly MD is a healthcare services and technology company that offers solutions for sleep support, pain treatment, and medication management through advanced data analytics. The company integrates mental health services, traditional medication, and plant-based alternatives to provide comprehensive, whole-person treatment. Dedicated to promoting abrighter, healthier future, Kindly MD delivers personalized care that addresses the unique needs of each patient.
Catena Labs — Catena is a product studio where we transform complex computing advancements into accessible, practical tools for users and developers. Leveraging AI and web3 technology our aim is to turn innovative ideas into real-world applications that are easy to use.

Sam Altman is the CEO and co-founder of OpenAI. He is a Partner of Apollo Projects. Altman was the president of Y Combinator from 2016 through 2019. Sam Altman attended Stanford University.

Investment focus

Software, Artificial Intelligence, Internet
Seed, Series A, Series B
United States, Canada, Ghana

Portfolio highlights

Exowatt — Modular full-stack renewable energy solutions for commercial and industrial customers.
Rescale — Rescale is a high performance computing cloud simulation platform that helps engineers and scientists build, compute, analyze, and scale simulations with high performance computing and automations.
Campus — Live courses with top professors.

Chris Gibson is the Co-Founder and CEO of Recursion (Recursion Pharmaceuticals). He previously worked at Cure HHT as a Member Board of Directors. Chris Gibson attended the University of Utah.

Investment focus

Biotechnology, Health Care, Life Science
Series A, Seed
United States, France, Switzerland

Portfolio highlights

Amenities Health — Amenities is the healthcare industry's leading Digital Front Door and patient loyalty platform. We help healthcare providers to acquire new patients and upgrade them to members. Our all-in-one patient app works with most modern EMRs to: 1) register new users into a full EMR account in <30 seconds with full identity verification and noduplicates, 2) help those patients find care options and book appointments with simple, conversion-optimized workflows, 3) seamlessly integrates key patient portal and 3rd party functions (i.e., video visits, secure messaging, test results, and billing), and 4) upgrade patients to members with custom experiences and services offerings (i.e., for Medicare Advantage, concierge memberships, direct-to-employer, or direct primary care patients)
Cradle — Engineer Better Proteins Faster. AI for modern protein engineering teams.
Leash Biosciences — We're transforming drug design with a rich dataset built by screening millions of compounds against thousands of protein to generate billions of data points, ideal for training advanced machine learning models.

Sahin Boydas is the founder of Stealth AI Startup. He previously served as the Head of Turkiye, Distributed Teams, Bootcamp, and App Ecosystem at Gusto. He attended Koç University.

Investment focus

Software, Financial Services, FinTech
Seed, Series A, Series B
United States, Mexico, Spain

Portfolio highlights

CapStack Technologies — Discover Capstack, the leading bank-to-bank marketplace driving banking digital transformation. Join the innovation wave and transform your banking experience now!
Sully.ai — Sully is deploying autonomous medical workers into healthcare organizations to address the most expensive line item in healthcare: payroll ($800b/yr in the US alone). Today, Sully's autonomous workers can perform most medical staff tasks 100x faster and 20x cheaper. From Digital Triage Nurses and Autonomous Medical Assistants to DigitalScribes and Digital Receptionists, our workers can automate patient check-in, assessments, documentation, diagnosis support, and billing that integrates with Electronic Health Records (EHRs)
Pallet — Pallet is a all-in-one logistics solution that integrates a Transportation Management System (TMS) and Warehouse Management System (WMS), to billing and reporting. Schedule a demo to see the future of modern freight businesses.

Wei Guo, the founding partner of UpHonest Capital, is an active angel investor in Silicon Valley, focusing on early-stage cross-sector investments. He founded Wei Fund in 2015 and UpHonest Capital Fund I in 2016, invested in well-known companies such as Hims&Hers(NYSE: HIMS), Vicarious Surgical(NYSE: RBOT), Knightscope (NASDAQ: KSCP), Checkr,Lime, Boom, Rescale, Dialpad and more. Since 2015, he has invested in over 400 Silicon Valley startups, over 76 companies with valuations greater than 100 million USD, and 23 portfolio companies that have successfully exited.

Investment focus

Software, Artificial Intelligence, Health Care
Seed, Series A, Angel
United States, China, Canada

Portfolio highlights

Golden — Golden is a developer of a self-constructing knowledge database used to accelerate discovery and education. The company uses and leverages human effort by using machine intelligence to make the process of gathering and communicating knowledge simpler.It combines a powerful search across several entities with fine-grain alerts to stay on top ofchanges, and semi-automatic research assistance for gaps in knowledge that enable people in organizations to stay current, understand and leverage the latest trends in their industry.
Playbook — Playbook gives creators the opportunity to build and grow a subscription business. Fans get an all-access pass to a curated health and wellness content.
Crossing — Crossing Media is a live broadcast e-commerce service company that builds awareness, engagement, and sales through live-stream shopping.

Nadav leads Taboola’s expansion and operations in Europe and Australia.Prior to joining Taboola, Nadav was a member of the founding team of Groupon UK & IR, taking part in building and managing Groupon’s business in the UK.Before joining Groupon, Nadav worked as a strategy consultant with McKinsey & Company in London.Nadav isbased in London and holds an MBA from INSEAD, France.

Investment focus

Biotechnology, Artificial Intelligence, Software
Seed, Pre-Seed, Series A
United Kingdom, France, Israel

Portfolio highlights

thymia — Making mental health as objectively measurable as physical health.
Loops — With Loops causal insights you can identify your biggest opportunities to maximize your KPIs... try the Loops way
Lindus Health — Lindus Health. From recruitment to delivery, we accelerate clinical trials. Our mission is to make health research accessible for everyone, everywhere.

Bradley Horowitz is an Advisor and Vice President of Product Management at Google. Most recently he helped create Area 120, Google's incubator for internally-sourced innovation. He's led a large number of products, programs and initiatives at Google - including Google for Startups, Google Photos, Gmail, Google Voice, blogger, and GoogleNews.Before joining Google in February 2008, Horowitz was Yahoo's vice president of Advanced Development where he drove the acquisitions of Flickr and MyBlogLog, launched the Brickhouse incubator and developed new products like Yahoo! Pipes. Additionally, he was responsible for the company's initiative to open up its platform which included overseeing the Yahoo Developer Network (YDN).Previously, he was co-founder and CTO of Virage, where he oversaw the technical direction of the company from its founding through its IPO and eventual acquisition by Autonomy.Horowitz was a PhD candidate at the MIT Media Lab. While at the Media Lab, he worked on a number of topics related to computer vision, graphics and image processing, which resulted in a patented new technique for the recovery of structure, motion and camera parameters from video sequences.Horowitz holds an MS in Media Science from MIT and a BS in Computer Science from the University of Michigan.

Investment focus

Software, Information Technology, Health Care
Seed, Series A, Series B
United States, United Kingdom, Germany

Portfolio highlights

/dev/agents — /dev/agents platform will work on new UI patterns that make it easier to build AI agents in a new cloud-based operating system.
Catena Labs — Catena is a product studio where we transform complex computing advancements into accessible, practical tools for users and developers. Leveraging AI and web3 technology our aim is to turn innovative ideas into real-world applications that are easy to use.
OrgOrg — OrgOrg provides internal SaaS tools for organizational productivity suite for the companies

Before co-founding Flatiron, Zach was Co-Founder, President and COO of Invite Media, an advertising technology company based in NYC. Invite Media built the industry's first enterprise advertising platform for buying and optimizing online media in real-time. Invite Media was acquired by Google in 2010. Prior to Invite Media, Zach co-foundedEatNow.com which was privately acquired. An active angel investor, Zach has invested in over 30 technology startups throughout the country, including Bell Biosystems, Breakthrough.com, Care at Hand, DocPhin, Doctor Evidence, Genomera, Meddik, Oscar, and Predilytics. Zach studied economics and entrepreneurship at The Wharton School at the University of Pennsylvania.

Investment focus

Health Care, Software, SaaS
Seed, Series A, Pre-Seed
United States, Israel, United Kingdom

Portfolio highlights

Scoop — Thrive in a hybrid work environment with Scoop's solutions for Workplace Safety, Workplace Utilization, Team Coordination, Desk Management, and Commute.
Crosby — Crosby is a company with programmers from Ramp, Vanta, Meta, and Google joining attorneys.
Overwatch Research — Generate accurate in vivo study data as a part of your efficient, connected R&D.

Elad Gil is the Co-Founder of Color Genomics. He previously worked at Twitter as a Vice President. Elad Gil attended the Massachusetts Institute of Technology.

Investment focus

Software, Information Technology, Artificial Intelligence
Seed, Series A, Series B
United States, United Kingdom, Israel

Portfolio highlights

Ashby — Ashby is a developer of recruitment software used for high-growth companies. It develops usable, enterprise-grade employment software that enables company leaders, recruiters, and hiring managers to run their hiring process significantly better. It was founded in 2018 and is based in San Francisco, California.
Harvey — Harvey is an artificial intelligence technology service provider.
Applied Intuition — Applied Intuition enables engineering and product development teams to safely develop, test, and deploy autonomous vehicles at scale.

Stefano Bernardi is the Investment Director, Climate at Fondazione ENEA Tech.

Investment focus

Biotechnology, Software, Artificial Intelligence
Seed, Pre-Seed, Funding Round
United Kingdom, Italy, France

Portfolio highlights

Freatic — Building the monetization layer for your alpha
CaSRevolution — A novel disease-modifying approach against neurodegeneration
Automated Architecture — A global ecosystem of automated micro-factories, to deliver sustainable, affordable and beautiful architecture to millions of people.

Evan Cheng Co-founder & CEO at Mysten Labs. He attended Syracuse University.

Investment focus

Software, Artificial Intelligence, Biotechnology
Seed, Pre-Seed, Funding Round
United States, United Kingdom, Australia

Portfolio highlights

Jarsy — Jarsy Inc offers a platform for global investment opportunities using stablecoins.
PIN AI — PIN AI democratizes personal on-device intelligence for everyone; transform your digital footprints into your Personal Executive Assistant.
Verida — The Verida Wallet is a mobile application that allows you to manage your decentralized identity and personal data. It provides a user-friendly interface for interacting with applications built on the Verida network.

Peter Thiel Is the Managing Partner of The Founders Fund. He previously worked at Stanford Law School as a Visitor. Peter Thiel attended Stanford University.

Investment focus

Software, Financial Services, FinTech
Series A, Seed, Series B
United States, Germany, Canada

Portfolio highlights

Rescale — Rescale is a high performance computing cloud simulation platform that helps engineers and scientists build, compute, analyze, and scale simulations with high performance computing and automations.
Mercor — Mercor is a better way to find opportunities. We're an AI-powered platform that sources, vets, and pays your next team members.
Quantum Systems — Our vision is to become the global leader in providing aerial data for decision making by the use of our drones.

Daniel Curran is the Founder and CEO at CustEx.com.

Investment focus

E-Commerce, Software, Internet
Seed, Series A, Series B
United States, Canada, Brazil

Portfolio highlights

CARD.com — Fully featured bank account with optional overdraft protection and round up savings account. Get your paycheck up to 2 days earlier.
RentoMojo — RentoMojo is an online furniture rental platform that was incorporated in November 2014.It currently operates in Bangalore, Pune, Mumbai, Hyderabad, Chennai, Delhi, Gurgaon and Noida.RentoMojo was founded by Geetansh Bamania, an ex-IITM, in November 2014 in India. Like many other young working professionals, he was living in rented apartments,working long hours and found it inconvenient to equip the house with furniture when he moved. RentoMojo was developed to provide an alternative to buying and selling furniture in rental properties.
GC Plus — Find Your Next Home Service Expert With Ease

Jan joined Index in 2010, and is a London-based partner, focusing on fintech and information/data services across all stages of growth.He is one of Index Ventures’ leading fintech investors, working with the founders of Adyen, Credit Benchmark, Robinhood and TransferWise. In all, Index has backed more than two dozen fintech companies, withmore than $400 million. Jan has also led Index investments and is on the boards of Beamery, Collibra, SafetyCulture and Silverfin.Before he joined Index, Jan was at General Atlantic in London, where he worked on investments in Kaspersky Lab, Northgate Information Solutions and Torex Retail. He also worked in the M&A, TMT and Capital Markets divisions at Morgan Stanley. Jan is a graduate of Oxford University, and holds an MBA with Distinction from INSEAD.

Investment focus

Health Care, Medical, Medical Device
Series A, Series B, Seed
China, United States, United Kingdom

Portfolio highlights

MacroLux — MacroLux Medical Technology Co., Ltd.
Yuetong Eye Clinic — Yuetong Eye Clinic is a medical institution that provides myopia surgery for adults and myopia prevention and control for adolescents. It is a medical institution focusing on adult myopia surgery and adolescent myopia prevention and control.
Xiwei Biotechnology — Xiwei Biotechnology is an ophthalmology implanted medical device developer that specializes in the unique product development of new bio-modified materials for ocular implantable medical devices and regenerative medicine.

Kevin Moore has 10 years experience as an angel/opportunity investor and operator. Prior to that, he has over 15 years of progressive technology i-banking, corp dev, and CFO experience at startups and $Bn corporates.

Investment focus

Software, Health Care, E-Commerce
Seed, Pre-Seed, Angel
United States, India, Canada

Portfolio highlights

Redbird — Redbird is an operating system that empowers data driven teams to easily create custom applications that automate advanced analytics work in minutes, without writing code.
SilkChart — SilkChart helps growth teams improve campaigns based on what users are doing in product - without relying on expensive data scientists. We do this through a no code analytics tool that combines marketing and product usage data to identify which channels, audiences, and content maximize revenue growth.
Augmend — Create documentation and an AI assistant from any video.

Anne Wojcicki is the Co-Founder and CEO of 23andMe. She previously worked at Passport Capital as a Healthcare Analyst. Anne Wojcicki attended Yale University.

Investment focus

Health Care, Medical, Biotechnology
Seed, Series A, Series B
United States, United Kingdom, Canada

Portfolio highlights

World Labs — World Labs is an AI startup that can analyze visual data with comprehension akin to a person's, a substantial advancement above existing capacities.
Solace — Connect with expert patient advocates who can help you navigate the healthcare system and solve any medical problem, no matter what you need.
Endo Health — Reverse Your Diabetes With a Game

Charles Songhurst is a founding partner of Katana Capital, a long-short equity hedge fund. He also runs the Songhurst Group, which holds assets in a variety of private companies.Charles ran corporate strategy for Microsoft and focused on partnering and M&A. He was involved in the Yahoo acquisition and commercial deal, and the Skypeacquisition. Before running corporate strategy, Charles was focused on the emergence of Google and the growth of the search industry.Prior, Charles was an analyst at McKinsey & Company in London. Charles received a bachelor’s degree from Oxford University in politics, philosophy, and economics.

Investment focus

Software, Information Technology, Artificial Intelligence
Seed, Pre-Seed, Funding Round
United Kingdom, United States, Germany

Portfolio highlights

Granola — Granola takes your raw meeting notes and makes them awesome. No awkward meeting bots - just beautiful notes for you and your team, every single time.
Dex — Dex is a SaaS company that offers an AI assistant to act as user's personal talent agent and scan the tech market for next opportunity.
YieldClub — YieldClub is a mobile app that helps you grow your savings with higher returns than a traditional bank.

Sake Bosch is a Founder and Managing Partner of Prime Ventures since 1999. Sake brings over 25 years of experience in marketing and sales and venture capital to Prime. Prior to founding Prime in 1999, Sake was a Senior Principal at Holland Venture and was responsible for managing investments in technology companies. Sake was involved in many ofthe Holland Venture technology investments including Applicare Medical Imaging (acquired by GE Medical Systems), BWise (acquired by Nasdaq), SQL Systems (acquired by Datastream) and Freecom (acquired by Mitsubishi Kagaku Media). Before joining Holland Venture in 1994, Sake worked as an Independent Corporate Finance Consultant focusing primarily on early stage companies. Prior to this position Sake was a Sales Executive at Securitas Group. Sake started his career in 1989 as a Strategic Market Analyst at VNU. Sake serves on the board of directors of Civolution, 4C, Dealerdirect, Digital Origin, Greetz, Forcare, SaaSPlaza, SlimPay and Takeaway.com. Previous investments include: 3mensio Medical Imaging (acquired by Esaoto), eBuddy (acquired by Booking.com), Global Collect (acquired by General Atlantic), MarketXS (acquired by Markit), Nedstat (acquired by comScore Inc.), Tridion (acquired by SDL) and Watermark (acquired by Qurius). Sake holds an M.Sc. degree in Business Administration as well as a B.A. degree in Management Science and Industrial Engineering.

Investment focus

Software, E-Commerce, Biotechnology
Seed, Series A, Series B
The Netherlands, France, Israel

Portfolio highlights

Faircraft — A sustainable, lab-grown alternative to animal leather.
FononTech — FononTech specializes in impulse printing.It is used to print small electronic circuits for electronic devices.
Mermade Seafoods — Mermade is a pioneering cellular aquaculture company, bringing a novel approach and mindset for the production of cell based seafood.

Bhavik Bajaj

Investment focus

Information Technology, Software, FinTech
Pre-Seed, Seed, Angel
United States, United Kingdom, Switzerland

Portfolio highlights

Asepha — Asepha is an AI clinical decision support (CDS) tool to help healthcare professionals make faster clinical decisions.
ORA Technologies — E-Commerce, Super App
THIRUMALS PAPER ARIZONA PVT. LTD. — TRADING PLATFORM OF PULP , PAPER & PACKAGING

Cory Levy is the Founder Advisor of Humaning.

Investment focus

Software, Artificial Intelligence, Advertising
Pre-Seed, Seed, Series A
United States, Canada, India

Portfolio highlights

CompLabs — CompLabs is focused on transforming engineering workflows by making high-fidelity simulation accessible, fast, and cost-effective for industries such as automotive, aerospace, and manufacturing.
Hidden Studios — Hidden Studios develops and advertises Fortnite Creative games, with 100M+ plays monthly. The company collaborated with prominent brands and creators, including Skydance, Snoop Dogg, and CaseOh, to deliver engaging gaming experiences. Hidden Studios maintains an active presence on YouTube, sharing content related to their Fortnite Creativeendeavors.
Swish Robotics — Embodied Intelligence for the Home

Farzad (Zod) Nazem has been a prolific angel investor and advisor to tech startup companies since his retirement from Yahoo! in 2007. He has invested in more than 60 early stage companies, and sits on the boards of Hand Foundation, and The Nueva School. His area of investment is about two thirds Big Data and Cloud platforms, and one third Healthand Medical. He was the Executive Vice President of Engineering and Chief Technology Officer of Yahoo from 1996 to mid 2007. He helped acquire and integrate over 50 companies and managed over six thousand engineers representing half of the company's employees. Between 1985 and 1996, Mr. Nazem held various software development and management positions at Oracle Corporation culminating in his role as Vice President of Media and Web Server Division. His tenure at Oracle also included membership in the company's Product Division Management Committee, which set overall strategy for Oracle products. Previously, Mr. Nazem was recruited from California Polytechnic State University by Rolm Corporation to be a software engineer in the VLCBX division. At age 19, he earned a B.S. degree in Computer Science with highest honors.

Investment focus

Health Care, Analytics, Machine Learning
Seed, Series A, Series B
United States, Canada

Portfolio highlights

Emailage — Emailage is a developer of fraud prevention and identity verification technology used to make transactions easier and secure. The company provides multi-faceted predictive solutions with email at the core through key partnerships, proprietary data, and advanced machine-learning technology. It proprietary algorithms in order to provide real-timealerts of risky transactions and delivers a risk score and enable companies to realize significant savings from identifying and stopping fraudulent transactions and improve customer experience.
Ceevra — Ceevra is an advanced 3D visualization technology for surgeons. Using AI and other innovative computing techniques, Ceevra generates brilliant 3D digital models from standard CT scans and MRIs. Surgeons use the Ceevra 3D models to help educate and counsel patients, to decide on the best surgical approach, and to gain important insights whileoperating.
TigerGraph — TigerGraph is a scalable graph analytics platform for big data, AI, and machine learning, enabling deep insights and complex relationship exploration.

Brian Armstrong is the CEO and Co-Founder of Coinbase. He previously worked at Airbnb.com as a Technical Product Manager. Brian Armstrong attended Rice University.

Investment focus

Payments, Financial Services, Biotechnology
Seed, Series A, Series B
United States, Brazil

Portfolio highlights

NewLimit — NewLimit is extending human healthspan by unlocking regenerative potential.
Stark Bank — Stark Bank is a smart bank account that aids a technological advancement of a company. It is a financial technology that allows companies to expand their operations by allowing them to make extra transfers, payments, and charges.
Orchid — Orchid is a reproductive technology startup that is capable of detecting rare genetic disorders. Orchid’s preconception system analyzes both partners’ genomes and assesses genetic predispositions to common diseases, including heart disease, stroke, schizophrenia, Alzheimer’s disease, breast cancer, and diabetes. Orchid results are developed withworld-class experts in reproductive medicine and genetics to give its clients the most accurate results.Orchid offers a “Couple Report” that utilizes an at-home saliva test to analyze each person’s genomes to detect the probability of genetic risks, then models how their DNA together will combine in a future child. If elevated risk is detected, Orchid provides insights to help couples monitor biomarkers, adapt their diet or elect for procedures, such as in vitro fertilization. It was founded by Noor Siddiqui in 2019 and is headquartered in San Francisco, California.

Erik Peterson is the Founder at DormTrader.

Investment focus

Software, Biotechnology, SaaS
Seed, Equity Crowdfunding, Series A
United States, Canada, Algeria

Portfolio highlights

Hideout — Hideout makes high-quality food that is available for delivery. Danielle Sobel established the company in Los Angeles, California.
Abalone Bio — Our Functional Antibody Selection Technology platform (FAST) taps into the potential of the body's biological activities, expanding the reach of antibody drugs.
Altay Therapeutics — Pioneering the first oral drug for FSHD and advancing cancer treatment solutions.

Mark Cuban is the founder of Fireside, Chairman and Founding Partner of AXS TV, and the Owner of Dallas Mavericks. He previously worked at Broadcast.com as a Co-Founder. Mark Cuban attended the Indiana University Bloomington.

Investment focus

Software, Artificial Intelligence, Blockchain
Seed, Series A, Funding Round
United States, United Kingdom, Singapore

Portfolio highlights

ESAI — Join over 450,000 students crafting their story
Kind Designs — We specialize in Seawall Construction using advanced 3D-printing technology in Florida. Get a free consultation today!
Campus Ink - NIL Store — Campus Ink Screen Printing & Embroidery, Champaign - Urbana, Custom T-Shirts, Fraternity & Sorority Apparel Simple

Xavier Niel is the Co-Founder and CEO of NJJ Capital. He previously worked at Worldnet as a Founder. Xavier Niel attended Saint Michel de Picpus Catholic private high school.

Investment focus

Software, Artificial Intelligence, SaaS
Seed, Series A, Funding Round
France, United States, United Kingdom

Portfolio highlights

Pixmania — Pixmania is an e-commerce website that provides buying and selling of speakers, cameras, headphones, and mobile devices.
Genesis AI — Genesis AI operates as a physical AI lab and full-stack robotics company.
Mobile Club — Mobile.club is a smartphone rental without obligation.

Marty Chavez is executive vice president and chief financial officer of The Goldman Sachs Group, Inc. He is a member of the Management Committee, Firmwide Capital Committee, Firmwide Risk Committee and Steering Committee on Regulatory Reform. Marty is also a member of the Firmwide Hispanic/Latino Network and the Lesbian, Gay, Bisexual andTransgender Network.Marty first joined Goldman Sachs in 1993 in the J. Aron Currency and Commodities Division, where he was a senior energy strat until 1997. He returned to the firm as a managing director in Investment Banking Division Strats in 2005, becoming global co-head of Securities Division Strats and then global co-chief operating officer of the Equities Franchise. Prior to assuming his current role, Marty was chief information officer, responsible for the Technology Division and jointly responsible with divisional leadership for the firm’s global strategists. He was named partner in 2006.Prior to first joining the firm, Marty was co-founder and chief technology officer of Quorum Software Systems from 1989 to 1993. From 1997 to 2000, he was global head of energy derivatives at Credit Suisse Financial Products. In 2000, Marty co-founded Kiodex, Inc. and was chairman and chief executive officer until 2004.Marty serves on the Harvard Board of Overseers and is a Fellow of the New York Academy of Medicine.Marty earned a PhD in Medical Information Sciences from Stanford University in 1990, an SM in Computer Science from Harvard University in 1985, and an AB, magna cum laude, in Biochemical Sciences from Harvard College in 1985.

Investment focus

Health Care, Machine Learning, Biotechnology
Series A, Seed, Private Equity
United States, United Kingdom

Portfolio highlights

Somite — Somite.ai is on a mission to transform the lives of millions of people by leveraging AI to produce human tissue for cell-based therapies.
Samaya AI — Expert AI Agents for Financial Services
VMind AI — VMind is a frontier technology company building artificial general intelligence (AGI).

Tom Williams

Investment focus

Software, Health Care, Financial Services
Seed, Series A, Series B
United States, Canada, India

Portfolio highlights

Unito — Enterprise-grade integrations that sync business-critical tools. Secure, low-cost, two-way sync that anyone can set up and manage.
Delphia — Invest with your data, not your money.
North One — NorthOne is an online Business Account with built-in features to make business banking fast and easy. No overdraft fees. No minimum balance. No hidden fees.

Bernard Majoie - President @ Fournier-Majoie

Investment focus

Biotechnology, Medical, Health Care
Seed, Pre-Seed, Series A
France, Belgium

Portfolio highlights

reMYND — Driving the development of disease-modifying treatments
AgenT — AgenT develops the first blood diagnosis to detect Alzheimer's years before the onset of the irreversible symptoms.
PEP-Therapy — PEP-Therapy is a French biotechnology company developing first-in-class peptides as targeted therapies in oncology

Dr Rand Hindi is an entrepreneur and investor in 50+ deeptech and web3 companies. He is the CEO at Zama, a homomorphic encryption startup. Rand started coding at the age of 10, created a social network at 14, and started his PhD at 21. He then created Snips, the first private-by-design voice assistant, which was acquired by Sonos. He was electedan MIT TR35, a Forbes “30 under 30”, and was a lecturer at Sciences Po in Paris as well as a member of the French Digital Council.He holds a BSc in Computer Science and a PhD in Bioinformatics from University College London (UCL).

Investment focus

Cryptocurrency, Software, Information Technology
Seed, Pre-Seed, Funding Round
France, United States, Germany

Portfolio highlights

Twin — Agentic AI, made actionable.
Usual — Usual Labs operates as a decentralized finance(DeFi) protocol.
Brink Therapeutics — Brink Therapeutics is a Biotechnology Research firm conducting cell therapy research using reprogrammed recombinases.

Daren was the Founder and CEO of InboxDollars, an online marketing company that connects consumers and advertisers in a way that benefits both. He founded the company as a Freshman in college in 2000 and bootstrapped the company to more than $25 million in annual revenues. InboxDollars was acquired by Prodege in 2019. Daren is active in the MNstart-up community as an investor, advisor and mentor.

Investment focus

Software, E-Commerce, Information Technology
Seed, Series A, Funding Round
United States

Portfolio highlights

Bonsai — Bonsai is the first-party marketing intelligence platform that automates profitable growth. Trust your marketing data, make confident decisions, drive revenue.
Franzy — Franzy is the "Zillow for franchising"—a smarter, more transparent way to find, compare, and finance franchise opportunities. We match aspiring entrepreneurs with the right franchise brands based on their goals, experience, and budget, making the path to business ownership simpler, faster, and more accessible.
Bonsai Data Solutions — Bonsai is the first-party marketing intelligence platform that automates profitable growth. Trust your marketing data, make confident decisions, drive revenue.

Dr. Fong is a Professor Emeritus at the Faculty of Medicine, University of Calgary. He was formerly the Head of the Department of Radiology at the University of Calgary and the Calgary Health Region. Dr. Fong is active in funding and nurturing start-up companies. Over the past two decades, he funded over 50 companies in diverse technology sectors,with an emphasis in medical devices. Dr. Fong is the co-founder and board member of Calgary Scientific Inc. and is also on the board of Clarius Mobile Health, Cohesic Inc. and Innovere Medical. In addition to seed investing, Dr. Fong is active in the Calgary community sitting on six charitable boards and foundations.In 2015, Dr. Fong joined the Creative Destruction Lab (CDL) at the University of Toronto business school as a mentor. CDL helps young entrepreneurs to shape or pivot their nascent ideas. He is widely credited with launching CDL at the Haskayne School of Business at the University of Calgary, bringing together seasoned business leaders from Alberta, Canada and the US to grow budding companies. Dr. Fong is on the Strategic Advisory Board of CDL and a Fellow of CDL in Toronto, Montreal, Calgary and Vancouver. In 2017, Dr. Fong was named to the Order of Canada for his contribution to medical technology innovation and philanthropy.

Investment focus

Software, Artificial Intelligence, Biotechnology
Seed, Angel, Pre-Seed
Canada, Singapore, United States

Portfolio highlights

Oncoustics AI — Oncoustics is creating and deploying advanced AI solutions for low cost, non-invasive surveillance, diagnostics, and treatment monitoring of diseases with high unmet clinical need. Unlike other players in the space, Oncoustics does not do image recognition. Instead, Oncoustics applies AI to raw ultrasound signals from readily available handheldultrasound devices to rapidly differentiate healthy versus diseased tissues. There's a wealth of information in these raw signals and this approach reveals novel biomarkers that can be aligned with existing standards and categorization systems. Initially targeting liver disease, a $30B global diagnostic market, Oncoustics has filed a Breakthrough Device Designation Request with the FDA for the OnX that detects liver fibrosis and the 510K is underway. Several follow-on liver products are in development. Oncoustics also has clinical data on other organ indications including prostate, kidney, breast and thyroid diseases and cancers.
SunGreenH2 — SunGreenH2 creates the world's highest performance advanced materials for electrolysis i.e. green hydrogen production. Achieve high efficiency, low cost green H2 production on site for your application in the Power-to-X, Hydrogen refuelling, Energy Storage and Buildings sectors. Revolutionising zero emissions and improving profitability.
EZee Assist — EZee Assist provides instant answers to franchisee operational questions. Continue using preferred channels of support and start receiving instant answers.

Bill Gates is the Co-chair of Bill and Melinda Gates Foundation. He attended Harvard University.

Investment focus

Biotechnology, Energy, Manufacturing
Series A, Series B, Series C
United States, Brazil, Canada

Portfolio highlights

Heineken — Welcome to the global website for Heineken International. Find information about our company, history, brands, strategy and careers here.
Inflection AI — Inflection AI is a machine learning startup that engages in redefining human-computer interaction.
Lucy Therapeutics — Lucy Therapeutics, a Boston-based biotech with a unifying mitochondrial platform, is developing small molecule treatments for neurological diseases.

Jack Abraham is the Founder and Managing Partner of Atomic. He previously worked at TalkIQ as a Co-founder and Investor. Jack Abraham attended The Wharton School.

Investment focus

Health Care, Biotechnology, Financial Services
Seed, Series A, Series B
United States

Portfolio highlights

Gameto — Gameto is a new breed of biotechnology company in female reproductive longevity
Arago — Arago is an AI and computer hardware company developing an energy-efficient AI chip powered by light, and its associated software.
Software Applications Incorporated — Rethinking the personal computing experience

Candan Karabagli - Yönetim Kurulu Başkanı, CHAIRMAN @ GS Yuasa

Investment focus

Retail, Analytics, Biopharma
Seed, Angel, Series A
Turkey

Portfolio highlights

Biolive — Biolive
Vispera — Drive your retail execution to perfection with Vispera image recognition technologies and intelligent retail solutions.
PhiTech Bioinformatics — PhiTech pioneers the integration of DNA & RNA sequencing data with AI for rare disease diagnostics. We offer the first RNA-based diagnostic support tool.

Penny Schiffer - CEO & Co-founder @ Raized.ai

Investment focus

Health Care, Medical, Finance
Funding Round, Seed, Series A
Switzerland, Germany, United Kingdom

Portfolio highlights

Versameb — Versameb AG is a preclinical-stage biopharmaceutical company located in Basel, Switzerland managed by an experienced scientific and business pharmaceutical industry team. The company’s focus is the development of novel RNA-based therapeutics. Versameb’s proprietary VERSagile technology platform enables efficient development of functional mRNAmolecules for customized protein expression and modification in multiple disease areas with high unmet medical need.
Enterprise Bot — Cost-effective Conversational AI solutions transforming customer interaction for global enterprises. Discover cutting-edge chat, email, and voice tech.
Scientific Visual — Scientific Visual supplies quality control workstations to visualize defects in non-polished sapphire such as watch covers, ingots and wafers.

Avichal is Managing Partner at Electric Capital. He is a serial entrepreneur and technology executive. Avichal sold two companies and was most recently Director of Product at Facebook, which acquired his company Spool in 2012. He previously worked at Google on search ranking and ads ranking, is part-time at YCombinator, and an active angelinvestor.Avichal's firm, Electric Capital, focuses on cryptocurrencies that are rooted in technological utility. Electric performs deep technological diligence, such as compiling code, profiling nodes, and analyzing blockchains with in-house software. The founders of Electric have started and sold five companies, have been investing in cryptocurrencies since 2013, and are investors in Anchor, Bitwise, Chia, Coda, dYdX, Dfinity, Oasis, Thunder and many other crypto projects.

Investment focus

Software, Blockchain, Internet
Seed, Series A, Funding Round
United States, Canada, Mexico

Portfolio highlights

Key — Unlock new networking and career opportunities with Key, the leading AI-powered professional networking platform. Build and manage communities, host and join exclusive events, and create meaningful connections to supercharge your growth all in one place.
Matic — The world's most advanced floor cleaner. Your home's best helper.
Bluenote Health — Accelerate innovation with AI built for and trusted by leading life sciences companies.

Annie Vereecken

Investment focus

Biotechnology, Medical, Hospital
Seed, Series A, Funding Round
Belgium

Portfolio highlights

Ziphius — Ziphius Vaccines is a biopharmaceutical company dedicated to developing next-generation vaccines for the prevention of infectious diseases.
Sensolus — Introducing our smart, industrial-grade tracking solution. With battery life of up to ten years, and no additional infrastructure needed.
Allegro Biotech — Allegro has developed the world’s-first custom-tailored, durable, biocompatible, anisotropic, regenerative meniscus cartilage, providing immediate support while also leverage the body’s own healing potential to regenerate human cartilage (proliferation and differentiation of fibrochondrocyte cells).

David is a Partner of Amplify Partners and co-founder of Chartio.com.Before joining Amplify Partners, David spent time as both a venture-backed entrepreneur and an early-stage investor. He began his career in technology as the co-founder and CEO of Chartio.com, a pioneering provider of cloud-based data visualization and analytics. He wassubsequently part of the founding team at Patients Know Best, one of the world’s leading cloud-based personal health record companies. David has been a prolific investor and advisor to entrepreneurs. He has personally invested in more than 50 early-stage companies, including Zymergen, Skycatch, Caribou Biosciences, Rigetti Computing, Casetext, Ginkgo Bioworks, Function of Beauty, Cruise Automation, and Bugcrowd. In addition, he currently serves on the advisory council of Bayes Impact, a nonprofit organization that deploys data science to solve important social challenges.He attended Brown University.

Investment focus

Software, Artificial Intelligence, Enterprise Software
Seed, Angel, Series A
United States

Portfolio highlights

Airtable — Airtable is a cloud-based software company that offers an easy-to-use online platform for creating and sharing relational databases.It brings the database out of the realm of power users and into the mainstream, creating a new type of flexible but sophisticated productivity tool that anyone can use. Airtable gives end-users the ability to createand share their own workflows for everything from managing an editorial calendar to planning a major event. The platform helps create flexible checklists, organize collections or ideas, and manage customers or contacts as well as offers a variety of templates ranging from home improvement to store inventory, enabling users to build custom applications without any prior coding experience.The company was founded by Andrew Ofstad, Emmett Nicholas, and Howie Liu in 2013 and is headquartered in San Francisco, California.
Astranis — Four billion people still have no internet access. Astranis is here to change that. We're making small satellites for geostationary orbit, recently signed a contract to triple the satellite internet capacity of Alaska, and raised our Series A from Andreessen Horowitz.
Ginkgo Bioworks — Ginkgo Bioworks is a biotechnology firm. It is a developer of biological engineering products and custom microbes across multiple markets. It designs, engineer, develops, tests, and licenses organisms. It discovers molecules in flavors, sweeteners, cosmetic ingredients, crop treatments, and pharmaceuticals. It also provides probiotic bacteria toprotect the body from dangerous infections, and it generates libraries of molecules. It serves cultured ingredients, carbon mitigation, probiotics, and natural product discovery markets.

John is the Founder and CEO of Capture Collective.

Investment focus

Biotechnology, Medical, Health Care
Seed, Funding Round, Equity Crowdfunding
United States

Portfolio highlights

RenovoDerm — A medical device company building a line of wound care products that provide a structure for tissue growth and promote faster healing of wounds—while reducing scar tissue. Funding prior to formation: $1.6 million.
Vascular Genesis — A medical device company laying the foundation for vascular conduit replacement with its line of cell-free, synthetic scaffold products -- with self-healing capabilities that lower the risk of rejection, infection, and stenosis. Funding prior to formation: $2.5 million.
Atreon Orthopedics — A medical device company building a line of orthopedic products that provide a structure for tissue growth and healing of sports medicine injuries including tendon ruptures/tears.